Zobrazeno 1 - 10
of 11
pro vyhledávání: '"S M, Brichard"'
Publikováno v:
Diabetes. 39:1326-1332
Autor:
S S, Amin, K, Cryer, B, Zhang, S K, Dutta, S S, Eaton, O P, Anderson, S M, Miller, B A, Reul, S M, Brichard, D C, Crans
Publikováno v:
Inorganic chemistry. 39(3)
The syntheses and the solid state structural and spectroscopic solution characterizations of VO(Me-acac)2 and VO(Et-acac)2 (where Me-acac is 3-methyl-2,4-pentanedionato and Et-acac is 3-ethyl-2,4-pentanedionato) have been conducted since both VO(acac
Publikováno v:
The Journal of clinical endocrinology and metabolism. 84(11)
Plasma levels of type 1 plasminogen activator inhibitor (PAI-1), a risk factor for cardiovascular disease, are elevated in obese subjects, especially those with omental fat accumulation. We investigated the hormonal control of PAI-1 gene expression a
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(3)
The direct role of hormones on leptin synthesis has not yet been studied in cultured adipose cells or tissue from lean and obese subjects. Moreover, this hormonal regulation has never been addressed in human visceral fat, although this site plays a d
Autor:
S. M. Brichard
Publikováno v:
Vanadium Compounds: Biochemical and Therapeutic Applications ISBN: 9781461285335
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a77752616ec55fd57f766bf54d25eb1b
https://doi.org/10.1007/978-1-4613-1251-2_14
https://doi.org/10.1007/978-1-4613-1251-2_14
Autor:
J C, Henquin, S M, Brichard
Publikováno v:
Presse medicale (Paris, France : 1983). 21(24)
The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?
Publikováno v:
Diabetemetabolisme. 17(5)
Vanadium is a trace metal that has raised increasing interest in diabetology since the discovery of its insulin-like properties in vitro and in vivo. This brief article is a review of the most recent data concerning the cellular mechanisms by which v
Publikováno v:
Annales de cardiologie et d'angeiologie. 39(8)
We studied the effects of perindopril, an angiotensin converting enzyme (ACE) inhibitor administered during 12 months, on creatinine clearance, albuminuria and glycaemic control in diabetic subjects with mild to moderate hypertension. After 1 month p
Publikováno v:
Diabetemetabolisme. 16(1)
We studied the effects of perindopril, an angiotensin converting enzyme (ACE) inhibitor administered during 12 months, on creatinine clearance, albuminuria and glycaemic control in diabetic subjects with mild to moderate hypertension. After 1 month p
Autor:
S. M. Brichard
Publikováno v:
Hormone & Metabolic Research; Jun2003, Vol. 35 Issue 6, p337, 6p